Antares Therapeutics
Antares Therapeutics is seeking a technically driven Sr. Scientist II/ Principal Scientist to join the Chemical Biology team and independently drive chemoproteomic target discovery and validation efforts. This senior individual-contributor role focuses on hit identification and characterization to support the company's small molecule discovery portfolio. The position involves developing novel mass spectrometry-based proteomic approaches and utilizing advanced instrumentation to elucidate mechanisms of action.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Antares Therapeutics.
36% above the average for this role